Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2007
View Archived Issues
COURAGE study finds PCI not beneficial in medically treated coronary artery disease
Read More
Promising in vivo results with a novel HPV vaccine for the treatment of cervix cancer
Read More
Snapshots: Recent findings for ceftobiprole
Read More
Studies show activity of ITMN-191 with other agents
Read More
Recent patents disclose novel agents for obesity and metabolic disorders
Read More
Recent BioTie patent claims novel therapeutic agents for thrombosis and related disorders
Read More
SurModics signs expanded corporate technology agreement with St. Jude Medical
Read More
New PMEG prodrug with improved therapeutic index designed by Gilead
Read More
ME-3738 protects against acetaminophen-induced liver injury in mice
Read More
Novel agents for treating sepsis disclosed in recent Sankyo patent
Read More
Enrollment completed for phase II osteoporosis study of NB-S101
Read More
BZL-101 begins phase I/II trial in advanced breast cancer
Read More
Protalix cleared to begin phase III study of prGCD for Gaucher's disease
Read More
SynCo and Prosensa sign service agreement for RNA therapeutics for DM
Read More
MM-093 studied in phase II for rheumatoid arthritis
Read More
Two phase II/III trials evaluate NT-501 in retinitis pigmentosa
Read More
Cortex submits Ampakine CX-717 data package to FDA
Read More
Sciele studies pravastatin and fenofibrate combination in phase II
Read More
Update on phase IIa MS study of ATL-1102
Read More
Development of new water-soluble topoisomerase I inhibitor reported by Chugai
Read More
Phase III trials planned for novel antiplatelet therapy SCH-530348
Read More
CovX designs Ang2-targeted antibody with promising antitumor activity
Read More
PF-337210, a new, selective, orally bioavailable VEGFR-2 inhibitor
Read More
ADX-10059 achieves statistically significant outcome in GERD study
Read More
Zenvia improves pain rating scale in painful diabetic neuropathy
Read More
Ostarine improves insulin resistance in elderly patients
Read More
Comtan launched in Japan
Read More
Swedish approval for Rapydan local anesthetic patch
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe